Skip to main content
FinSpry Logo
FinSpry
URGN logo
URGN
(NASDAQ)
UroGen Pharma Ltd.
$30.22-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

UroGen Pharma (URGN) Stock Price & Financial Analysis

UroGen Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.43 - $30.32
52-Week High$32.37
52-Week Low$3.42
Open$28.78
Volume785.24K
Average Volume (3M)952.76K
Market Cap1.36B
Shares Outstanding48.12M
Price to Sales (P/S)12.39
Price to Book (P/B)-12.89
EV/EBITDA-10.34
Revenue (TTM)109.79M
Net Income (TTM)-153.49M
Free Cash Flow (TTM)-162.73M
EPS (TTM)$-3.19
Profit Margin-139.81%
Operating Margin-113.73%
50-Day MA$21.30
200-Day MA$20.83
52-Week Change181.24%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About UroGen Pharma

What is the current stock price for URGN?

As of the latest trading session, URGN stock trades at $30.22. The 52-week range is $3.42–$32.37, with a day range of $28.43–$30.32.

What is the P/E ratio for URGN?

The P/E ratio (Price-to-Earnings) for URGN is shown in the Key Statistics section. This valuation metric helps compare UroGen Pharma Ltd. to industry peers.

Does URGN pay dividends?

UroGen Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for URGN?

Based on 1 analyst, the consensus for URGN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of URGN?

UroGen Pharma's market capitalization is $1.45B, classifying it as a small-cap company. UroGen Pharma operates in the Healthcare sector within the Biotechnology industry.